Rare diseases
Investigational molecules
Locations
Back to France1 521 clinical trials in Toulouse, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes
FranceStudy on Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer Using a Response-Adapted Strategy
FranceStudy Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant
FranceStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
FranceStudy on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
FranceStudy on the Safety and Effectiveness of Furmonertinib vs. Platinum-Based Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
FranceStudy on the Effectiveness and Safety of Iptacopan for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Switching from Anti-C5 Antibody Treatment
FranceStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
FranceStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
FranceStudy on the Long-Term Safety of Sacituzumab Govitecan for Patients with Metastatic Solid Tumors
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart disease treatment, including trials for TTR amyloidosis and prevention of heart failure. Advanced therapeutic approaches using novel compounds like baxdrostat in combination with established medications.
Comprehensive cancer research targeting multiple types of malignancies, including head and neck cancer, gastric cancer, and advanced pancreatic cancer. Novel approaches using targeted therapies and immunotherapy combinations.
Advanced research in neurodegenerative conditions and movement disorders, including studies on frontotemporal dementia, essential tremor, and traumatic brain injury outcomes.
Studies investigating new treatments for inflammatory diseases, including innovative approaches for Crohn's disease, psoriatic arthritis, and myasthenia gravis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
